Nuggets for innovative drugs Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research

  • Post date May 9, 2022 — 02:16 Post Lock Login to View

Key Data Concepts:   
? These are the company names, stock quotes, topics, and entities related to this data.

000925 002014 002422 300322 China Shipbuilding Industry Group Power Citic Securities Fujian Funeng Guotai Junan Securities Huangshan Novel Huizhou Speed Wireless Technology Jiangsu Hengrui Medicine Nanjing Pharmaceutical Shanghai Fosun Pharmaceutical Sichuan Kelun Pharmaceutical Unittec Xiamen Amoytop Biotech Xinjiang Sayram Modern Agriculture Zhejiang Huahai Pharmaceutical Witness Accounting, Audit Layoffs, Downsizing Management Annual, Special Corporate Meeting Annual Report Research, Development Health, Beauty Product Pharmaceutical Financial, Business Service Gold, Precious Material Paper, Packaging Product Credit, Debt Currency Market, Exchange Securities Stocks Cancer Epidemic Hospital Medicine Small, Medium Enterprise Series Economy, Business, Finance Health

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets


Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!


Already have an account?
Login



Related Data